← Back to all trials
Completed
NCT04281732
Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision
Conditions: Low Vision, Retinitis Pigmentosa, Stargardt Disease 1, Stargardt Disease 3, Stargardt Disease 4, Albinism
Sex: All
Ages: 20 Years – 50 Years
Enrollment: 18
Sponsor: Queen's University, Belfast
Location: NI Clinical Research Facility Belfast Northern Ireland
Summary
Purpose:
To validate a newly developed battery of performance-based tests of visual function to be presented using virtual reality. The tests are intended as potential outcome measures for clinical trials of treatments of eye disease: they measure visual performance in patients with low vision on visual tasks that a relevant for daily life.
Eligibility Criteria
Inclusion Criteria:
1. Male and female participants
2. Age 20-50
3. Bilateral sight impairment due to Stargardt's disease, retinitis pigmentosa or albinism.
4. Sight impairment criteria are as follows:
* Visual acuity of 3 / 60 to 6 / 60 with a full field of vision.
* Visual acuity of up to 6 / 24 with a moderate reduction of field of vision
Exclusion Criteria:
1. Any physical impairment that would make use of the virtual reality headset difficult or unsafe.
2. A history of vertigo or dizziness.
Source: ClinicalTrials.gov (NCT04281732). StuddyBuddy aggregates publicly available trial information.
